Virid­i­an inks $185M fi­nanc­ing, hires three Ma­gen­ta ex­ec­u­tives as CEO Scott My­ers ex­its

Stephen Ma­honey joined Virid­i­an Ther­a­peu­tics as CEO on Mon­day, with the for­mer Ma­gen­ta Ther­a­peu­tics pres­i­dent mark­ing the au­toim­mune biotech’s third chief ex­ec­u­tive in less than 12 months.

Ma­honey re­places Scott My­ers, who had led AM­AG Phar­ma­ceu­ti­cals be­fore sign­ing on as Virid­i­an CEO in Feb­ru­ary when he filled in for Jonathan Vi­o­lin. Sun­day was My­ers’ last day af­ter an “in­vol­un­tary ter­mi­na­tion,” per a Mon­day morn­ing SEC fil­ing. Shares of Virid­i­an $VRDN were up al­most 9% af­ter the open­ing bell.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER